Skip to main content

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

VCNX holding history

Vaccinex, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VCNX overviewAll 13F holders of VCNXFull Q4 2025 holdings

Shares (Q1 2024)
0
Sold out in Q1 2024
Value
$0
% of portfolio
0.0%
Quarters held
12
Since Q1 2021
Holdings of VCNX by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20240$00.0%−48,221−100.0%Sold outHolders
Q4 202348,221$32.1K<0.1%00.0%UnchangedHolders
Q3 202348,221$54.5K<0.1%−636−1.3%ReducedConverted for a 1-for-15 splitHolders
Q2 2023732,859$260.9K<0.1%00.0%UnchangedHolders
Q1 2023732,859$292.8K<0.1%00.0%UnchangedHolders
Q4 2022732,859$472.3K<0.1%+694+0.1%AddedHolders
Q3 2022732,165$363.0K<0.1%+4,900+0.7%AddedHolders
Q2 2022727,265$785.0K<0.1%00.0%UnchangedHolders
Q1 2022727,265$960.0K<0.1%+104,083+16.7%AddedHolders
Q4 2021623,182$648.0K<0.1%00.0%UnchangedHolders
Q3 2021623,182$1.35M<0.1%+22,558+3.8%AddedHolders
Q2 2021600,624$1.68M<0.1%+356,374+145.9%AddedHolders
Q1 2021244,250$728.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.